Follow the conference on Twitter #IVTherapySummit
This conference focuses on IV access: managing uncompliant patients, and patients with difficult venous access. Difficulties in IV access due to individual patient factors or patients with difficult venous access often lead to repeated failed attempts which can result in delayed diagnosis and treatment.
“Many healthcare professionals have been involved with patients who were unable to cooperate with IV therapy and vascular access procedures. The uncompliant patient in healthcare is perhaps the most challenging aspect of this clinical specialism. Learning strategies to help the patient feel more involved and supported is key.”
Andrew Barton, Chair, NIVAS & Advanced Nurse Practitioner in Vascular Access and IV Therapy Frimley Health NHS Foundation Trust, June 2019
“Non-compliance in a treatment regime can bring many challenges. In outpatient antimicrobial therapy, non-compliance can bring an array of difficulties not seen in the general hospital population.”
Fiona Nadin, Clinical Nurse Specialist OPAT, Frimley Health NHS Foundation Trust, February 2019
This conference will enable you to:
- Learn from outstanding practice in managing difficult venous access
- Reflect on national developments and learning
- Improve the way you work with uncompliant patient groups including people with learning disabilities, children, IV drug users and people with needle phobia
- Develop your skills in vein assessment
- Understand patient suitability and assessment for OPAT
- Understand how you can improve vessel health and preservation
- Identify key strategies for improving success rates in vascular access
- Ensure you are up to date with the latest evidence
- Self assess and reflect on your own practice
- Gain CPD accreditation points contributing to professional development and revalidation evidence
PLUS: There will be an opportunity to hear from Pentland Medical in the pre-conference supplier showcase session.
100% of delegates at our previous conference on this subject would recommend it to a colleague
